DUCHESNAY Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DUCHESNAY, and what generic alternatives to DUCHESNAY drugs are available?
DUCHESNAY has three approved drugs.
There are eleven US patents protecting DUCHESNAY drugs.
There are one hundred and forty patent family members on DUCHESNAY drugs in forty-two countries and sixteen supplementary protection certificates in fourteen countries.
Drugs and US Patents for DUCHESNAY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | 9,937,132 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | 9,526,703 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | 9,089,489 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | AB | RX | Yes | Yes | 8,642,079 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | AB | RX | Yes | Yes | 9,855,224 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Duchesnay | DICLEGIS | doxylamine succinate; pyridoxine hydrochloride | TABLET, DELAYED RELEASE;ORAL | 021876-001 | Apr 8, 2013 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DUCHESNAY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | 7,560,122 | ⤷ Try a Trial |
Duchesnay | DICLEGIS | doxylamine succinate; pyridoxine hydrochloride | TABLET, DELAYED RELEASE;ORAL | 021876-001 | Apr 8, 2013 | 6,340,695 | ⤷ Try a Trial |
Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | 9,566,252 | ⤷ Try a Trial |
Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | 9,241,915 | ⤷ Try a Trial |
Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | 8,470,890 | ⤷ Try a Trial |
Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | 8,772,353 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for DUCHESNAY drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 20 mg/20 mg | ➤ Subscribe | 2018-08-28 |
➤ Subscribe | Delayed-release Tablets | 10 mg/10 mg | ➤ Subscribe | 2013-08-01 |
International Patents for DUCHESNAY Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112017004190 | ⤷ Try a Trial |
Mexico | 360662 | ⤷ Try a Trial |
South Korea | 20030048378 | ⤷ Try a Trial |
Poland | 1713458 | ⤷ Try a Trial |
Eurasian Patent Organization | 032671 | ⤷ Try a Trial |
Australia | 2005215174 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for DUCHESNAY Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1713458 | 132016000023047 | Italy | ⤷ Try a Trial | PRODUCT NAME: OSPEMIFENE IN TUTTE LE FORME PROTETTE DAL BREVETTO DI BASE(SENSHIO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/978/001-002, 20150115 |
1713458 | 2015/031 | Ireland | ⤷ Try a Trial | PRODUCT NAME: OSPEMIFENE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEREOF; REGISTRATION NO/DATE: EU/1/14/978/001-002 20150115 |
1713458 | PA2015023,C1713458 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: OSPEMIFENAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/14/978/001, 2015 01 15 EU/1/14/978/002 20150115 |
1713458 | C300742 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: OSPEMIFEEN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/14/978 20150115 |
1713458 | PA2015023 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: OSPEMIFENUM; REGISTRATION NO/DATE: EU/1/14/978/001, 2015 01 15 EU/1/14/978/002 20150115 |
1713458 | 1590030-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: OSPEMIFENE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/14/978/001 20150119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.